Henry Schein | HSIC - Ebitda


Henry Schein reported $289M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Agilent USD 456M 84M Dec/2025
Align Technology USD 260.87M 77.03M Dec/2025
Bruker USD 110M 101.6M Mar/2026
Cardinal Health USD 1.09B 109M Mar/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Cigna USD 2.86B 56M Mar/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
CVS Health USD 5.83B 2.08B Mar/2026
Danaher USD 1.92B 204M Mar/2026
Dentsply International USD 129M 6M Mar/2026
Encompass Health USD 348.8M 13.2M Mar/2026
Henry Schein USD 289M 2M Mar/2026
Idexx Laboratories USD 400.87M 45.95M Mar/2026
IQVIA Holdings USD 932M 114M Mar/2026
Laboratory Of America USD 605.6M 17.5M Mar/2026
McKesson USD 1.88B 206M Dec/2025
Mettler Toledo International USD 278.99M 100.24M Mar/2026
Owens Minor USD 90.02M 2.15M Dec/2025
Quest Diagnostics USD 557M 20M Mar/2026
Revvity USD 272.91M 24M Mar/2026
Stryker USD 1.57B 618M Mar/2026
Tenet Healthcare USD 1.16B 21M Mar/2026
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Universal Health Services USD 678.67M 8.07M Dec/2025
Veradigm USD 38.81M 29.61M Sep/2022
Waters USD 380.97M 85.83M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025
Zoetis USD 939M 101M Dec/2025